According to the Zhitong Finance App, Shandong Xinhua Pharmaceutical Co., Ltd. (00719.HK) announced its 2026 interim results, with operating income of about 4.358 billion yuan, a year-on-year decrease of 6.06%; net profit attributable to shareholders of listed companies was about 149 million yuan, a year-on-year decrease of 33.35%; and basic earnings per share were 0.21 yuan.

Zhitongcaijing · 4d ago
According to the Zhitong Finance App, Shandong Xinhua Pharmaceutical Co., Ltd. (00719.HK) announced its 2026 interim results, with operating income of about 4.358 billion yuan, a year-on-year decrease of 6.06%; net profit attributable to shareholders of listed companies was about 149 million yuan, a year-on-year decrease of 33.35%; and basic earnings per share were 0.21 yuan.